NantHealth, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NantHealth, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2022.
  • NantHealth, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $206M, a 9.88% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $206M +$18.5M +9.88% Dec 31, 2022 10-K 2023-04-14
Q4 2021 $187M +$23.4M +14.3% Dec 31, 2021 10-K 2023-04-14
Q4 2020 $164M +$10.4M +6.76% Dec 31, 2020 10-K 2022-02-25
Q4 2019 $153M +$12.6M +8.93% Dec 31, 2019 10-K 2021-02-26
Q4 2018 $141M +$43.5M +44.7% Dec 31, 2018 10-K 2020-02-28
Q4 2017 $97.3M +$9.03M +10.2% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $88.3M +$57.4M +186% Dec 31, 2016 10-K 2018-03-16
Q4 2015 $30.9M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.